FDA Disclaimer: BPC-157 is an investigational research peptide not approved by the FDA for human use. The FDA has stated it presents "significant safety risks." All information on this page is for educational and research purposes only. Nothing here constitutes medical advice. Consult a licensed physician before considering any peptide protocol.

BPC-157 Dosage Guide: Research Protocols, Injection Methods, and Reconstitution

TLDR: BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein, developed by researchers at the University of Zagreb. Animal studies use doses ranging from 1 to 10 mcg/kg, administered subcutaneously or intramuscularly. No approved human dosing exists. The FDA classifies BPC-157 as a compound presenting "significant safety risks." This guide covers what published research actually shows about protocol variables - not dosage recommendations.

What Is BPC-157?

BPC-157 is a synthetic pentadecapeptide - a chain of 15 amino acids - derived from a protein found in human gastric juice. This BPC-157 dosage guide focuses on what published animal research actually shows about protocol variables: dose ranges, administration routes, and reconstitution. The name stands for Body Protection Compound 157. Most of the published research comes from the University of Zagreb in Croatia, where Predrag Sikiric and colleagues have studied the compound since the 1990s.

That origin matters. The Zagreb research group has produced an impressive volume of animal data, but independent replication is limited. When you read claims about BPC-157, a significant portion trace back to a single lab and a single team. That is not a reason to dismiss the research, but it is a reason to read it carefully.

Animal studies have investigated BPC-157 across a wide range of applications: gut healing, tendon repair, muscle regeneration, neurological protection, and bone healing. The compound appears to influence nitric oxide signaling pathways and angiogenesis - the formation of new blood vessels - which researchers think may explain some of its effects on tissue repair.

BPC-157 is not approved for human use anywhere in the world. The FDA has stated it presents "significant safety risks," not merely that data is insufficient. That distinction matters for anyone reading these studies in a research context.

Affiliate Disclosure: PeptidePick participates in affiliate programs. Some links on this page are affiliate links, which means we may earn a commission if you make a purchase. This comes at no extra cost to you and does not influence our editorial content. We only recommend vendors we have independently evaluated. See our full affiliate disclosure policy.